Sorrento Therapeutics, Inc. /
Virex Health, Inc.
Sorrento Therapeutics completes acquisition of Virex Health
- Terms
- Not stated
- Stage
- Closed
What happened
Sorrento Therapeutics, Inc. completed its acquisition of Virex Health, Inc. on February 1, 2022. The transaction included adjusted closing consideration of $11,566,275, with up to $10,000,000 in additional consideration tied to regulatory milestones.
Virex develops diagnostic solutions for COVID-19 testing and early cancer detection.
The source
Everything on this page comes from the source below.
Sorrento Therapeutics completes acquisition of Virex Health
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly